EENet Connect

Harvard researchers are advising millions of people who take aspirin every day to prevent heart attacks to stop their daily use.

Some 29 million people 40 and older were taking an aspirin a day in 2017 despite not having a…

Registration is now open the Knowledge Translation Professional Certificate (KTPC) October 21-25, 2019, presented by the Hospital for Sick Children (SickKids) and the University of Toronto.

Apathy is the most common neuropsychiatric symptom of dementia, with a bigger impact on function than memory loss. A new study has found that apathy is present nearly half of all people with dementia, with researchers finding it is often distinct from depression.

Although common,…

Leading the way in Mental Health Training and Education

A program of therapy and coping strategies for people who care for family members with dementia successfully improves the carers' mental health for at least a six-year follow-up.

Carers who took part in the program were five times less likely to have clinically significant depression than…

A new study, published in Psychiatry Research, has concluded that psychiatric diagnoses are scientifically worthless as tools to identify discrete (either you have it or you don't) mental health disorders.

The main findings of the research were:

Good afternoon,

I recall a few months back CAMH hosted a grand round webinar on gay, bi, queer men and substance use.

Hoping someone can connect me to the recording of the presentation or the staff person that delivered it.

Many thanks,

Dane Griffiths, Associate Director…

Researchers want to understand why you may or may not have accessed naloxone - including what makes it easier or more difficult to access - among individuals with past or current experience taking opioids for chronic pain in order to improve naloxone policies and programs.

According to Statistics Canada, 23% of high school students across the country have tried a vaping product. Of that total, teens and young adults — between the ages of 15 and 24 — report the highest rates of vaping.

“It’s the ‘in’ thing now,” said Robert Schwartz, a senior scientist at the…